United Therapeutics highlights new data supporting two FDA filings

United Therapeutics raised expectations for U.S. FDA approval by presenting new clinical trial data on a pulmonary disease treatment at a European medical conference.

View Source Article ↗

AI CATALYST SCORE75 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

Diagnosed At	Ticker	AI Score	Tier
2026-08-30 22:01:39	UTHR	75	Mid	View Report →
2026-08-15 04:53:05	UTHR	40	Row	View Report →
2026-08-14 03:31:29	UTHR	40	Row	View Report →

United Therapeutics highlights new data supporting two FDA filings

UTHR Analysis History (Last 30 Days)